Tocilizumab, sold under the brand name Actemra among others, is an immunosuppressive drug, used for the treatment of rheumatoid arthritis, systemic juvenile...

dexamethasone (a steroid, which reduces inflammation) Intravenous immunoglobulin Tocilizumab (an anti-inflammatory) Anakinra (an anti-inflammatory) The following...

beneficial or not as it has not been studied. Injections of tocilizumab may also be used. Tocilizumab is a humanized antibody that targets the interleukin-6...

negating the effect of drugs intended to activate the immune system. Tocilizumab, an anti-IL-6 monoclonal antibody, was FDA approved for steroid-refractory...

cyclophosphamide therapy has failed. Furthermore, should DMARDs fail, tocilizumab can be used for tumor necrosis factor (TNF) inhibitor treatments in NICE...

prostate cancer. Tocilizumab was jointly developed by Osaka University and Chugai, and was licensed in 2003 by Hoffmann-La Roche. Tocilizumab was approved...

hydroxychloroquine, penicillamine, azathioprine, methotrexate, etanercept, anakinra, tocilizumab, cyclophosphamide, adalimumab, rituximab, and infliximab. Newer medications...

unresponsive to TNF inhibitors. The first approved medication in this class, tocilizumab (Actemra), is an antibody directed against the IL6-receptor. The second...

also be used. There is tentative evidence for selenium in mild disease. Tocilizumab, a drug used to suppress the immune system has also been studied as a...

[citation needed] Promising results are achieved with mycophenolate and tocilizumab. If treatment is not kept to a high standard, long-term damage or death...